Effects of Extended Release Niacin added to Simvastatin/Ezetemibe on Glucose and Insulin values in AIM HIGH

BACKGROUND: Niacin is an anti-dyslipidemic agent that may cause blood sugar elevation in patients with diabetes, but its effects on glucose and insulin values in non-diabetic statin-treated subjects with cardiovascular disease and at high risk for diabetes are less well known. METHODS: This was a pr...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am J Med
Hoofdauteurs: Goldberg, Ronald B., Bittner, Vera A., Dunbar, Richard L., Fleg, Jerome L., Grunberger, George, Guyton, John R., Leiter, Lawrence A., McBride, Ruth, Robinson, Jennifer G., Simmons, Debra L., Wysham, Carol, Xu, Ping, Boden, William E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914402/
https://ncbi.nlm.nih.gov/pubmed/27036394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2016.02.039
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items